Regulation of low-density lipoprotein receptor activity by estrogens and phytoestrogens in a HepG2 cell model

Annals of Nutrition and Metabolism

Volumn 48, Issue 4, 2004, Pages 269-275

  Owen, Alice J ^a,c   Roach, Paul D ^b   Abbey, Mavis ^b  

^a UNIVERSITY OF ADELAIDE   (Australia)

^b CSIRO   (Australia)

^c UNIVERSITY OF WOLLONGONG   (Australia)

Author keywords

Antioxidant; Estrogen; Isoflavone; Low density lipoprotein; Phytoestrogen; Receptor, LDL

Indexed keywords

BIOCHANIN A; COUMESTROL; DAIDZEIN; ENTERODIOL; ENTEROLACTONE; ESTRADIOL; ESTRIOL; FORMONONETIN; ISOFLAVONOID; LIGNAN DERIVATIVE; LOW DENSITY LIPOPROTEIN RECEPTOR; PHYTOESTROGEN;

ANTIOXIDANT ACTIVITY; ARTICLE; CELL CULTURE; CELL STRAIN HEPG2; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG EFFECT; DRUG RECEPTOR BINDING; ESTROGEN ACTIVITY; HORMONAL REGULATION; HUMAN; HUMAN CELL; INCUBATION TIME; PRIORITY JOURNAL; RECEPTOR UPREGULATION;

CARCINOMA, HEPATOCELLULAR; CELL LINE; CHOLESTEROL, LDL; DOSE-RESPONSE RELATIONSHIP, DRUG; ESTRADIOL; ESTROGENS; GENE EXPRESSION REGULATION; HUMANS; LIVER; LIVER NEOPLASMS; PHYTOESTROGENS; RECEPTORS, LDL; TUMOR CELLS, CULTURED;

MAMMALIA;

EID: 6044231038     PISSN: 02506807     EISSN: None     Source Type: Journal    
DOI: 10.1159/000080462     Document Type: Article

References (49)

1. Walsh BW, Schiff I, Rosner B, Greenberg L, Ravnikar V, Sacks F: Effects of postmenopausal estrogen replacement on the concentrations and metabolism of plasma lipoproteins. N Engl J Med 1991;325:1196-1204.
2. Ogita H, Node K, Kitakaze M: The role of estrogen and estrogen-related drugs in cardiovascular diseases. Curr Drug Metab 2003;4:497-504.
3. Wren BG: The effect of estrogen on the female cardiovascular system. Med J Aust 1992;157:204-208.
4. Chao Y, Windler EH, Chen GC, Havel RJ: Hepatic catabolism of rat and human lipoproteins in rats treated with 17α-ethinyl estradiol. J Biol Chem 1979;254:11360-11366.
5. Roach PD, Noel S-P: Solubilisation of the 17-alpha ethinyl estradiol-stimulated low density lipoprotein receptor of male rat liver. J Lipid Res 1985;26:713-720.
6. Ma PTS, Yamamoto T, Goldstein JL, Brown MS: Increased mRNA for low density lipoprotein receptor in livers of rabbits treated with 17α-ethinyl estradiol. Proc Natl Acad Sci USA 1986;83:792-796.
7. Ferreri F, Naito NK: Effect of estrogens on rat serum cholesterol concentrations: Consideration of dose, type of estrogen and treatment duration. Endocrinology 1978;102:1621-1627.
8. Angelin B, Olivecrona H, Reihnér E, Rudling M, Ståhlberg D, Eriksson M, Ewerth S, Henriksson P, Einarsson K: Hepatic cholesterol metabolism in estrogen treated men. Gastroenterology 1992;103:1657-1663.
9. Semenkovich CF, Ostlund RE Jr: Estrogens induce low density lipoprotein receptor activity and decrease intracellular cholesterol in human hepatoma cell line HepG2. Biochemistry 1987;26:4987-4992.
10. Roach PD, Hosking J, Clifton PM, Bais R, Kusenic B, Coyle P, Wight MB, Thomas DW, Nestel PJ: The effects of hypercholesterolaemia, simvastatin and dietary fat on the low density lipoprotein receptor of unstimulated mononuclear cells. Atherosclerosis 1993;103:245-254.
11. Abbey M, Owen A, Suzukawa M, Roach P, Nestel PJ: Effects of menopause and hormone replacement therapy on plasma lipids, lipoproteins and LDL receptor activity. Maturitas 1999;33:259-269.
12. Schinckel PG: Infertility in sheep grazing on subterranean clover pastures. Observations on breeding behaviour following transfer to 'sound' country. Aust Vet J 1948;24:289-294.
13. Makela S, Poutanen M, Lehtimaki J, Kostian M-L, Santti R, Vihko R: Estrogen-specific 17β-hydroxysteroid oxidoreductase type 1 (EC 1.1.1.62) as a possible target for the action of phytoestrogens. Proc Soc Exp Biol Med 1995;208:51-59.
14. Collins BM, McLachlan JA, Arnold SF: The estrogenic and antiestrogenic activities of phytochemicals with the human estrogen receptor expressed in yeast. Steroids 1997;62:365-372.
15. Cassidy A: Potential tissue selectivity of dietary phytoestrogens and estrogens. Curr Opin Lipid 1999;10:47-52.
16. Siddiqui MT, Siddiqi M: Hypolipidemic principles of cicer arietinum: Biochanin A and formononetin. Lipids 1976;11:243-246.
17. Potter SM: Soy protein and serum lipids. Curr Opin Lipid 1996;7:260-264.
18. Nestel PJ, Yamashita T, Sasahara T, Pomeroy S, Dart A, Komesaroff P, Owen A, Abbey M: Soy isoflavones improve systemic arterial compliance but not plasma lipids in menopausal and perimenopausal women. Arterioscler Thromb Vasc Biol 1997;17:3392-2298.
19. Pal S, Bursill C, Bottema C, Roach PD: Regulation of the low density lipoprotein receptor by antioxidants; in Basu TK, Temple N, Garg MM (eds): Antioxidants in Human Health and Disease. Oxford, CABI, 1999, pp 55-69.
20. Lowry OH, Rosebrough NJ, Farr AL, Randall RJ: Protein measurement with the Folin phenol reagent. J Biol Chem 1951;193:265-275.
21. Chung BH, Segrest JP, Ray MJ, Brunzell JD, Hokanson JE, Krauss RM, Beaudrie K, Cone JT: Single vertical spin gradient ultracentrifugation. Methods Enzymol 1986;128:181-201.
22. Esterbauer H, Streigl G, Puhl H, Rotheneder M: Continuous monitoring of in vitro oxidation of human low density lipoprotein. Free Radic Res Commun 1989;6:67-75.
23. Jordan C, Koch R: Regulation of prolactin synthesis in vitro by estrogenic and antiestrogenic derivatives of estradiol and estrone. Endocrinology 1989;124:1717-1726.
24. Brzozowski AM, Pike AC, Dauter Z, Hubbard RE, Bonn T, Engström O, Öhman L, Greene G, Gustafsson J-A, Carlquist M: Molecular basis of agonism and antagonism in the estrogen receptor. Nature 1997;389:753-758.
25. Shwaery GT, Vita JA, Keaney JF Jr: Antioxidant protection of LDL by physiologic concentrations of estrogens is specific for 17-beta-estradiol. Atherosclerosis 1998;138:255-262.
26. Croston GE, Milan LB, Marschke KB, Reichman M, Briggs MR: Androgen receptor-mediated antagonism of estrogen-dependent low density lipoprotein receptor transcription in cultured hepatocytes. Endocrinology 1997;138:3779-3786.
27. Dodge JA, Glasebrook AL, Magee DE, Phillips DL, Sato M, Short LL, Bryant HU: Environmental estrogens: effects on cholesterol lowering and bone in the ovariectomized rat. J. Steroid Biochem Mol Biol 1996;59:155-161.
28. Collins BM, McLachlan JA, Arnold SF: The estrogenic and antiestrogenic activities of phytochemicals with the human estrogen receptor expressed in yeast. Steroids 1997;62:365-372.
29. Kuiper GGJM, Carlsson B, Grandien K, Enmark E, Häggblad J, Nilsson S, Gustafsson J-A: Comparison of the ligand binding specificity and transcript tissue distribution of estrogen receptors α and β. Endocrinology 1997;138:863-870.
30. Harnish DC, Evans MJ, Scicchitano MS, Bhat RA, Karathanasis SK: Estrogen regulation of the apolipoprotein AI gene promoter through transcription cofactor sharing. J Biol Chem 1998;273:9270-9278.
31. Tam S-P, Hache RJG, Deeley RG: Estrogen memory effect in human hepatocytes during repeated cell division without hormone. Science 1986;234:1234-1237.
32. Edmunds SEJ, Stubbs AP, Santos AA, Wilkinson ML: Estrogen and androgen regulation of sex hormone binding globulin secretion by a human liver cell line. J Steroid Biochem Molec Biol 1990;37:733-739.
33. Moore JT, McKee DD, Slentz-Kesler K, Moore LB, Jones SA, Horne EL, Su J-L, Kliewer SA, Lehmann JM, Willson TM: Cloning and characterisation of human estrogen receptor β isoforms. Biochem Biophys Res Commun 1998;247:75-78.
34. Zou A, Marschke KB, Arnold KE, Berger EM, Fitzgerald P, Mais DE, Allegretto EA: Estrogen receptor β activates the human retinoic acid receptor α-1 promoter in response to tamoxifen and other estrogen antagonists, but not in response to estrogen. Mol Endocinol 1999;13:418-430.
35. Prasad K, Mantha SV, Muir AD, Westcott ND: Reduction of hypercholesterolemic atherosclerosis by CDC-flaxseed with very low alpha-linolenic acid. Atherosclerosis 1998;136:367-375.
36. Wang H, Peters GA, Zeng X, Tang M, Ip W, Khan SA: Yeast two-hybrid system demonstrates that estrogen receptor dimerization is ligand-dependent in vivo. J Biol Chem 1995;270:23322-23329.
37. Martin ME, Haourigui M, Pelisseo C, Benassayag C, Nunez EA: Interactions between phytoestrogens and human sex steroid binding protein. Life Sci 1996;58:429-436.
38. Kitts DD, Yuan YV, Wijewickreme AN, Thompson LU: Antioxidant activity of the flaxseed lignan secoisolariciresinol diglycoside and its mammalian lignan metabolites enterodiol and enterolactone. Mol Cell Biochem 1999;202:91-100.
39. Kirk EA, Sutherland P, Wang SA, Chait A, LeBoeuf RC: Dietary isoflavones reduce plasma cholesterol and atherosclerosis in C57BL/6 mice but not LDL receptor-deficient mice. J Nutr 1998;128:954-959.
40. Akiyama T, Ishida J, Nakagawa S, Ogawara H, Watanabe S, Itoh N, Shibuya M, Fukami Y: Genistein, a specific inhibitor of tyrosine-specific protein kinases. J Biol Chem 1987;262:5592-5595.
41. Chan P-C, Lafreniere R, Parsons HG: Lovastatin increases surface LDL receptor expression by retarding the receptor internalisation rate in proliferating lymphocytes. Biochem Biophys Res Commun 1997;235:117-122.
42. Borradaile NM, DeDreu LE, Wilcox LJ, Edwards JY, Huff MW: Soya phytoestrogens, genistein and daidzein, decrease apolipoprotein B secretion fromHepG2 cells through multiple mechanisms. Biochem J 2002;366:531-539.
43. Wang W, Goodman MT: Antioxidant property of dietary phenolic agents in a human LDL oxidation ex vivo model: Interaction of protein binding activity Nutr Res 1999;19:191-202.
44. Miksicek RJ: Estrogenic flavonoids: Structural requirements for biological activity. Proc Soc Exp Biol Med 1995;208:44-50.
45. Javitt NB: HepG2 cells as a resource for metabolic studies: Lipoprotein, cholesterol and bile acids. FASEB J 1990;4:161-168.
46. Pal S, Ho N, Santos C, Dubois P, Mamo J, Croft K, Allister E: Red wine polyphenolics increase LDL receptor expression and activity and suppress the secretion of apoB100 from human HepG2 cells. J Nutr 2003;133:700-706.
47. Yu-Poth S, Yin D, Zhao G, Kris-Etherton PM, Etherton TD: Conjugated linoleic acid upregulates LDL receptor gene expression in Hep G2 cells. J Nutr 2004;134:68-71.
48. Salleh MN, Runnie I, Roach PD, Mohamed S, Abeywardena MY: Inhibition of low density lipoprotein oxidation and upregulation of low density lipoprotein receptor in HepG2 cells by tropical plant extracts. J Agric Food Chem 2002;50:3693-3697.
49. Wilson GM, Roberts EA, Deeley RG: Modulation of LDL receptor mRNA stability by phorbol esters in human liver cell culture models. J Lipid Res 1997;38:437-446.